Delivery Order SPE2DE21D7001-SPE2D625F93RB
Award Date
2/21/25
Potential Completion Date
2/27/25
Potential Value
$7.5K
Federal Agency
Medical Supply Chain
Awardee
Medtronic Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Spring Lake Park, MN 55432, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
This is a delivery order awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to Medtronic Inc., a global medical technology company, for the supply of biologics and synthetic medical products. The contract has a ceiling value of $8,862.55 and is a fixed-price with economic price adjustment arrangement. It does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Medtronic holds with the...
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the procurement of various medical supplies and equipment. The contract, valued at $19,060.80, does not have a set-aside designation and covers the delivery of biologics, including Grafton DBF bone graft products, with a final delivery date of September 6, 2024. Medtronic is a global leader in medical technology and a major supplier to the...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Medtronic Inc. through its Medtronic USA, Inc. division. The contract is for the procurement of Biologics - Synthetics-Mastergraft Strip medical supplies, with a ceiling value of $3,996.41 and a period of performance through January 7, 2025. The contract is a fixed-price with economic price adjustment and was not set aside for any specific business type. Medtronic is a global leader in medical technology,...
This federal contract award, valued at $5,702.85, was issued by the Defense Health Agency (DHA) to the prime contractor Medtronic Inc. The contract is a fixed-price delivery order with an economic price adjustment, and the ultimate completion date is January 28, 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Medtronic Inc., a global leader in medical technology, will provide biologics - specifically, a Grafton DBM Matrix -...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Health Agency (DHA), to Medtronic Inc. through its Medtronic USA, Inc. division. The $11,650.80 fixed-price delivery order is for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF, a biological medical product, with a completion date of May 15, 2024. The contract does not have a set-aside designation. Medtronic is a global leader in medical technology and has been awarded numerous firm fixed-price contracts...
This federal contract award is for the delivery of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical devices, valued at $6,720.30, by Medtronic Inc. through its Medtronic USA, Inc. division. The contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense, and does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. The company has a significant Indefinite Delivery...
This federal contract award was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $8,181.40 fixed-price delivery order contract is for the supply of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical products. Medtronic is a global leader in medical technology and has been awarded numerous federal contracts and grants to provide a wide range of innovative medical devices and therapies to the...